ArticleTrials2025

EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial.

Arnaud Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.